LP135650-2RivaroxabanActive
Description
LP135650-2 Rivaroxaban
Rivaroxaban is an oral anticoagulant, marketed as Xarelto. It is the first available orally active direct factor Xa inhibitor. Rivaroxaban is well absorbed from the gut and maximum inhibition of factor Xa occurs four hours after a dose. The effects lasts 8-12 hours, but factor Xa activity does not return to normal within 24 hours so once-daily dosing is possible.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Wikipedia
Basic Part Properties
- Name
- Rivaroxaban
- Type
- Component
- Created On
- 2011-09-30
- Construct for LOINC Short Name
- Rivaroxaban
LOINC FHIR® API Example - CodeSystem Request Get Info
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=LP135650-2
Language Variants Get Info
- zh-CNChinese (China)
- 利伐沙班
Synonyms: 5-氯-N-(((5S)-2-氧代-3-(4-(3-氧代吗啉-4-基)苯基)-1,3-恶唑啉-5-基)甲基)噻吩-2-甲酰胺;利伐沙班中间体; Rivaroxaban; 5-Chloro-N-(((5S)-2-oxo-3-(4-(3-oxomorpholin-4-yl)phenyl)-1,3-oxazolidin-5-yl)methyl)thiophene-2-carboxamide; Rivaroxaban intermediates; 5-chloro-N-[[(5S)-2-oxo-3-[4-(3-oxomo - nl-NLDutch (Netherlands)
- rivaroxaban
- it-ITItalian (Italy)
- Rivaroxaban
- ru-RURussian (Russian Federation)
- Ривароксабан
- es-ESSpanish (Spain)
- Rivaroxaban
- tr-TRTurkish (Turkey)
- Rivaroksaban
LOINC Copyright
Copyright © 2022 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright